CDEK
← All organizations

Arcutis, Inc.

For profitWebsite ↗

Also known as: ARCUTIS | Arcutis Biotherapeutics, Inc. | ARCUTIS BIOTHERAPEUTICS INC | Arcutis, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 11, 2017

First marketed drug

Jul 29, 2022

Last known activity

Sep 30, 2025

Timeline

2010s

  1. Jun 1, 2016

    Arcutis, Inc.— Founded

2020s

  1. Jul 29, 2022

    roflumilast— Marketing Organization

  2. Jul 29, 2022

    roflumilast— NDA Secondary Org

Drugs by trial phase (2 distinct, 25 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (38)

Details

Founded
Menlo Park, CA, US Jun 1, 2016
Last known activity
Sep 30, 2025